Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.
about
Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patientsMortality among methadone maintenance clients in China: a six-year cohort studyBaseline CD4 cell counts of newly diagnosed HIV cases in China: 2006-2012The prevalence of HIV-1 drug resistance among antiretroviral treatment naïve individuals in mainland China: a meta-analysisEfficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.The increased effectiveness of HIV preventive intervention among men who have sex with men and of follow-up care for people living with HIV after 'task-shifting' to community-based organizations: a 'cash on service delivery' model in ChinaPeer-based behavioral health program for drug users in China: a pilot studyChina AIDS policy implementation: reversing the HIV/AIDS epidemic by 2015.Addressing injecting drug use in Asia and Eastern Europe.Quality of life of people living with HIV/AIDS under the new epidemic characteristics in China and the associated factors.Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVPredictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men.Treatment to Prevent HIV Transmission in Serodiscordant Couples in Henan, China, 2006 to 2012Long-Term Effectiveness of Antiretroviral Therapy in China: An Observational Cohort Study from 2003-2014.Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China.Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaUnsafe Sex and STI Prevalence Among HIV-Infected Adults in Guangzhou, China: Opportunities to Deamplify Sexual HIV Transmission.Antiretroviral Therapy Initiation Following Policy Changes: Observations From ChinaImmunologic treatment failure among HIV-infected adult patients in Jiangsu province, China.Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
P2860
Q21134515-B4200EDA-105E-47C5-907C-87306FE7BCF6Q28486005-1B43E94A-6443-4868-AC73-C0388B025A04Q28537626-3C0ADF26-4EBB-476F-BA11-CF22060F3470Q28539411-12B40872-F30A-437D-84A2-6B2149BB5B9DQ28544113-F3F438FD-85B6-4801-B551-A0C09FF6A9BFQ33441858-3DB5BD73-484C-4A75-A24D-D63917C3378CQ33933505-E0CB8464-4B3B-40F3-AB05-78143BC32A02Q34013283-2F789C45-F9A9-42DB-9D92-676CD2E357F0Q34354354-AE30E3CB-3A42-48E9-853A-189D1DFC95D3Q34648865-72456A75-EF93-469D-AFC6-D9FEB69169ACQ34760552-F78364CA-D8CA-48D5-B44B-4312D9D853A0Q35102114-44125DC6-4214-4CC1-9FC8-02B48A6C7728Q35881070-EA7C0D2F-E168-429B-B383-F9836A89B9F4Q35975536-6EE6D1B5-E3A3-4009-BD9D-647DD6BBA2C6Q36012766-FA302908-F503-4294-800D-DAE0300EC6ECQ36419523-287DEB69-4DE0-43C9-975D-6AB735DB7BBEQ36706986-195FF86A-AB61-46CF-9CB0-6FD3A5CC25A6Q36792612-BED3A0F7-D970-47F4-BE91-1A32AFB10112Q37346206-83B5F709-50B0-4208-B4A0-64FB9B7A18E2Q37655103-F7229C2A-D9B6-433E-AD38-1CFF529857B5Q41187933-BEB0FA3A-4797-4000-A9B4-47C77E555FE3Q42216147-9AB38400-2669-4FDE-A19A-85DC2B795766Q42237320-AA8775C5-19C8-4591-A358-979C8D4937DCQ42982907-00636DE7-1533-413D-BD39-B32EE81338EC
P2860
Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Changing baseline characterist ...... al Treatment Program, 2002-09.
@ast
Changing baseline characterist ...... al Treatment Program, 2002-09.
@en
Changing baseline characterist ...... al Treatment Program, 2002-09.
@nl
type
label
Changing baseline characterist ...... al Treatment Program, 2002-09.
@ast
Changing baseline characterist ...... al Treatment Program, 2002-09.
@en
Changing baseline characterist ...... al Treatment Program, 2002-09.
@nl
prefLabel
Changing baseline characterist ...... al Treatment Program, 2002-09.
@ast
Changing baseline characterist ...... al Treatment Program, 2002-09.
@en
Changing baseline characterist ...... al Treatment Program, 2002-09.
@nl
P2093
P2860
P356
P1476
Changing baseline characterist ...... al Treatment Program, 2002-09.
@en
P2093
Decai Zhao
Fujie Zhang
Jiahong Xu
Jin Hua Jiao
Ray Y Chen
Stephen Durako
Zhihui Dou
P2860
P304
P356
10.1093/IJE/DYQ215
P478
39 Suppl 2
P577
2010-12-01T00:00:00Z